OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Asciminib in chronic myeloid leukemia: many questions still remain to be answered
Ahmet Emre Eşkazan
Blood Cancer Journal (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 6
Ahmet Emre Eşkazan
Blood Cancer Journal (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 6
Showing 6 citing articles:
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia
Yunfan Yang, Yuntao Liu, Hui Sun, et al.
Haematologica (2024)
Open Access | Times Cited: 4
Yunfan Yang, Yuntao Liu, Hui Sun, et al.
Haematologica (2024)
Open Access | Times Cited: 4
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial
Delphine Réa, Carla Boquimpani, Michael J. Mauro, et al.
Leukemia (2023) Vol. 37, Iss. 5, pp. 1060-1067
Open Access | Times Cited: 10
Delphine Réa, Carla Boquimpani, Michael J. Mauro, et al.
Leukemia (2023) Vol. 37, Iss. 5, pp. 1060-1067
Open Access | Times Cited: 10
Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Sara Malik, Shahzeb Hassan, Ahmet Emre Eşkazan
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 975-978
Open Access | Times Cited: 17
Sara Malik, Shahzeb Hassan, Ahmet Emre Eşkazan
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 975-978
Open Access | Times Cited: 17
Asciminib as a new option in the treatment of chronic myeloid leukemia
Betül İbiş, Mario Tiribelli, Ahmet Emre Eşkazan
Future Oncology (2021) Vol. 17, Iss. 36, pp. 5003-5005
Closed Access | Times Cited: 9
Betül İbiş, Mario Tiribelli, Ahmet Emre Eşkazan
Future Oncology (2021) Vol. 17, Iss. 36, pp. 5003-5005
Closed Access | Times Cited: 9
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
S.M. Arif, R. Andres Floto, Tom L. Blundell
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 5
S.M. Arif, R. Andres Floto, Tom L. Blundell
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 5
MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE
Sameen Shahid, Muhammad Farooq Sabar, Zafar Iqbal, et al.
International Journal of Pharmacy & Integrated Health Sciences (2023) Vol. 5, Iss. 1
Open Access
Sameen Shahid, Muhammad Farooq Sabar, Zafar Iqbal, et al.
International Journal of Pharmacy & Integrated Health Sciences (2023) Vol. 5, Iss. 1
Open Access
